Diabetic macular edema (DME) is a chronic condition with a multifactorial pathogenesis.
Vascular endothelial growth factor (VEGF) and several inflammatory mediators are …

Purpose To describe the common risk factors, complications, and management options for
anterior migration of Ozurdex implant. Methods A comprehensive review of the literature was …

We present patient characteristics and follow-up results of cases with anterior chamber
dexamethasone implant migration. The common feature of all six presented cases was …

Purpose: Ozurdex had shown promising anatomical and functional outcomes in managing
refractory Irvine–Gass syndrome over the years. Burgeoning usage of Ozurdex has …

In this paper, we introduce a mathematical model for the drug release from an intravitreal
implant and the subsequent effect of the drug on the inflammation process of macular …

Purpose Silicone oil (SO) has been used as a vitreous tamponade for decades. Surgical
complications such as glaucoma, cataract, or emulsification are well known. Despite that …

Objective To compare the rates of complications in eyes that received a dexamethasone
(DEX) implant (0.7 mg) or intravitreal triamcinolone (IVT)(2 mg) to treat postvitrectomy …

The aim of this multicenter, national clinical audit is to evaluate the predictive factors and
management of postoperative macular edema (ME) after retropupillary iris-claw intraocular …

In this paper we study from a mathematical point of view the drug release and the
degradation process in the context of biodegradable intravitreal implants. In particular, two …

Purpose. To report surgical management of ocular complications occurred after
dexamethasone (DEX) implant (Ozurdex®) injection. Methods. Retrospective interventional …